Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06256237
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-02-05
Brief Title:
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer A Phase 2 Trial
Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Organization:
Shanghai Pulmonary Hospital Shanghai China
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-05
First Submit QC Date:
February 5 2024
Study First Post Date:
2024-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-26
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL